The role of sunscreen in melasma and postinflammatory hyperpigmentation

Photosensitive conditions such as melasma and postinflammatory hyperpigmentation (PIH) are exacerbated by exposure to ultraviolet (UV) rays and visible light making sunscreen use an essential component of treatment. This is especially true in skin of color patients who are less likely to use photopr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Indian journal of dermatology Jg. 65; H. 1; S. 5 - 10
Hauptverfasser: Fatima, Sakeena, Braunberger, Taylor, Mohammad, Tasneem, Kohli, Indermeet, Hamzavi, Iltefat
Format: Journal Article
Sprache:Englisch
Veröffentlicht: India Wolters Kluwer India Pvt. Ltd 01.01.2020
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Schlagworte:
Care and treatment
Color
Dermatology
Hyperpigmentation
Melanosis
melasma
postinflammatory hyperpigmentation
Review
Self evaluation
Skin
Sunscreen
Sunscreening agents
Titanium
Toiletries industry
ultraviolet light
visible light
sunscreen
visible light
Melasma
postinflammatory hyperpigmentation
ultraviolet light
ISSN:0019-5154, 1998-3611, 1998-3611
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Photosensitive conditions such as melasma and postinflammatory hyperpigmentation (PIH) are exacerbated by exposure to ultraviolet (UV) rays and visible light making sunscreen use an essential component of treatment. This is especially true in skin of color patients who are less likely to use photoprotection, even if diagnosed with these photoexacerbated conditions. We aimed to evaluate the body of literature to provide evidence for the use of sunscreen in the treatment of melasma and PIH. We reviewed English articles from PubMed, Journals@Ovid Full Text, and Embase using the search terms "sunscreen" and either "melasma" "PIH," or "post-inflammatory hyperpigmentation." Nine relevant publications provide evidence that a broad spectrum of protection, including UVA, UVB, and visible light within sunscreens can play an adjuvant role in therapy for melasma and PIH by stabilizing and improving these pigmentary disorders in skin of color patients. This review illustrates the advantages and limitations of sunscreen use, as well as practice gaps in photoprotection in the skin of color patients with melasma and PIH.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ISSN:0019-5154
1998-3611
1998-3611
DOI:10.4103/ijd.IJD_295_18